Vertex Pharmaceuticals Inc (VRTX): Gross Profit
$10.35B
Year ended 2025-12-31
$10.82B
Trailing 12 months to 2026-06-30
+9.7%
3-year compound annual growth
+13.6%
5-year compound annual growth
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $10.35B | +9.1% | 2026-02-13, From 2025-01-01 |
| 2024-12-31 | $9.49B | +10.3% | 2026-02-13, From 2024-01-01 |
| 2023-12-31 | $8.61B | +9.6% | 2026-02-13, From 2023-01-01 |
| 2022-12-31 | $7.85B | +17.7% | 2025-02-13, From 2022-01-01 |
| 2021-12-31 | $6.67B | +22.0% | 2024-02-15, From 2021-01-01 |
| 2020-12-31 | $5.47B | +51.3% | 2023-02-10, From 2020-01-01 |
| 2019-12-31 | $3.62B | +37.0% | 2022-02-09, From 2019-01-01 |
| 2018-12-31 | $2.64B | +19.2% | 2021-02-11, From 2018-01-01 |
| 2017-12-31 | $2.21B | +48.4% | 2020-02-13, From 2017-01-01 |
| 2016-12-31 | $1.49B | n/a | 2019-02-13, From 2016-01-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $10.35B | +9.1% |
| Viatris Inc (VTRS) | 2025-12-31 | $5.01B | -10.8% |
| Zoetis Inc. (ZTS) | 2025-12-31 | $6.80B | +4.0% |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $8.94B | +10.8% |
| Organon & Co. (OGN) | 2025-12-31 | $3.31B | -10.8% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $4.67B | +45.3% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $2.59B | +6.4% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $1.49B | -3.1% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $3.04B | +56.4% |
Compare VRTX, VTRS, ZTS, TEVA side by side · Screen every company in Pharmaceutical Preparations ↗